These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26838761)

  • 1. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
    Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
    J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.
    Volgraf M; Sellers BD; Jiang Y; Wu G; Ly CQ; Villemure E; Pastor RM; Yuen PW; Lu A; Luo X; Liu M; Zhang S; Sun L; Fu Y; Lupardus PJ; Wallweber HJ; Liederer BM; Deshmukh G; Plise E; Tay S; Reynen P; Herrington J; Gustafson A; Liu Y; Dirksen A; Dietz MG; Liu Y; Wang TM; Hanson JE; Hackos D; Scearce-Levie K; Schwarz JB
    J Med Chem; 2016 Mar; 59(6):2760-79. PubMed ID: 26919761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zelquistinel acts at an extracellular binding domain to modulate intracellular calcium inactivation of N-methyl-d-aspartate receptors.
    Zhang XL; Li YX; Berglund N; Burgdorf JS; Donello JE; Moskal JR; Stanton PK
    Neuropharmacology; 2024 Nov; 259():110100. PubMed ID: 39117105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.
    Yao L; Zhou Q
    Neural Plast; 2017; 2017():2875904. PubMed ID: 28163934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
    Geoffroy C; Paoletti P; Mony L
    J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 7. A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine/D-serine.
    Guo H; Camargo LM; Yeboah F; Digan ME; Niu H; Pan Y; Reiling S; Soler-Llavina G; Weihofen WA; Wang HR; Shanker YG; Stams T; Bill A
    Sci Rep; 2017 Sep; 7(1):11608. PubMed ID: 28912557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.
    Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.
    Sapkota K; Irvine MW; Fang G; Burnell ES; Bannister N; Volianskis A; Culley GR; Dravid SM; Collingridge GL; Jane DE; Monaghan DT
    Neuropharmacology; 2017 Oct; 125():64-79. PubMed ID: 28709671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate.
    Yeboah F; Guo H; Bill A
    J Vis Exp; 2018 Jul; (137):. PubMed ID: 30059041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased modulators of NMDA receptors control channel opening and ion selectivity.
    Perszyk RE; Swanger SA; Shelley C; Khatri A; Fernandez-Cuervo G; Epplin MP; Zhang J; Le P; Bülow P; Garnier-Amblard E; Gangireddy PKR; Bassell GJ; Yuan H; Menaldino DS; Liotta DC; Liebeskind LS; Traynelis SF
    Nat Chem Biol; 2020 Feb; 16(2):188-196. PubMed ID: 31959964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
    Zhu S; Paoletti P
    Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites.
    Goldsmith PJ
    Curr Top Med Chem; 2019; 19(24):2239-2253. PubMed ID: 31660834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-cell patch-clamp analysis of recombinant NMDA receptor pharmacology using brief glutamate applications.
    Glasgow NG; Johnson JW
    Methods Mol Biol; 2014; 1183():23-41. PubMed ID: 25023300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents.
    Rook JM; Xiang Z; Lv X; Ghoshal A; Dickerson JW; Bridges TM; Johnson KA; Foster DJ; Gregory KJ; Vinson PN; Thompson AD; Byun N; Collier RL; Bubser M; Nedelcovych MT; Gould RW; Stauffer SR; Daniels JS; Niswender CM; Lavreysen H; Mackie C; Conde-Ceide S; Alcazar J; Bartolomé-Nebreda JM; Macdonald GJ; Talpos JC; Steckler T; Jones CK; Lindsley CW; Conn PJ
    Neuron; 2015 May; 86(4):1029-1040. PubMed ID: 25937172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
    Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE
    Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mGlu
    Ghoshal A; Moran SP; Dickerson JW; Joffe ME; Grueter BA; Xiang Z; Lindsley CW; Rook JM; Conn PJ
    ACS Chem Neurosci; 2017 Oct; 8(10):2254-2265. PubMed ID: 28679049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Screen of GluK1 Receptor Identifies Selective Inhibitors with a Variety of Kinetic Profiles Using Fluorescence and Electrophysiology Assays.
    Solly K; Klein R; Rudd M; Holloway MK; Johnson EN; Henze D; Finley MF
    J Biomol Screen; 2015 Jul; 20(6):708-19. PubMed ID: 25700884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.